8-KAccepted Sep 29, 4:11 PM ET
Bluerock Acquisition Corp. II Announces IPO Closing, $172.5M Raised
Accepted (ET)
4:11 PM
Sep 29, 2026
Filed
Sep 29, 2026
Documents
28
Size
1.8 MB
Summary
Bluerock Acquisition Corp. II Announces IPO Closing, $172.5M Raised
What Happened
Bluerock Acquisition Corp. II announced the closing of its initial public offering on September 28, 2026. The company sold 17,250,000 units (including a full 2,250,000-unit over-allotment) at $10.00 per unit, producing gross IPO proceeds of $172,500,000. Each unit contains one Class A ordinary share and one-half of a redeemable warrant (each full Warrant exercisable to buy one Class A share at $11.50, beginning 30 days after a business combination). Simultaneously, the company completed a private placement of 5,812,500 warrants at $1.00 each (gross $5,812,500) to the sponsor and the representative. A total of $173,362,500 (including deferred underwriter commission) was placed in a U.S. trust account held by Continental.
Key Details
- IPO units sold: 17,250,000 (includes 2,250,000 over-allotment); price: $10.00 per unit; IPO gross proceeds: $172,500,000.
- Private Placement Warrants: 5,812,500 warrants sold at $1.00 each (Sponsor: 3,862,500; Representative: 1,950,000); gross proceeds $5,812,500.
- Trust funding: $173,362,500 placed in trust (includes up to $6,037,500 underwriter deferred commission); funds restricted until a business combination, redemption events, or limited permitted releases.
- Governance and compensation: On Sept 24, 2026 the board added independent directors Christopher Bradley, Ziv Conen and Andrew Weksler; Bradley and Conen chair Audit and Compensation committee roles respectively; directors received Class B ordinary share awards (Bradley 30,000; Conen 25,000; Weksler 40,000). JBAAM (affiliate of Weksler) will be paid up to $7,500/month for up to 12 months for administrative services.
Why It Matters
The filing confirms Bluerock Acquisition II is now a public blank-check (SPAC) company with IPO proceeds secured in a trust account, governance in place, and sponsor-aligned incentives via private placement warrants. For investors, the trust restricts access to most funds until a qualifying business combination or specified redemption events; public shares can be redeemed if no business combination is completed within 21 months of the IPO. The warrant structure and sponsor holdings are key to understanding potential future dilution and alignment with management during the search for a target.